SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039170
Filing Date
2023-11-02
Accepted
2023-11-02 17:10:35
Documents
19
Period of Report
2023-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48299
2 ex4-1.htm EX-4.1 117571
3 ex4-2.htm EX-4.2 117768
4 ex4-3.htm EX-4.3 18115
5 ex4-4.htm EX-4.4 110074
6 ex10-1.htm EX-10.1 287255
7 ex10-2.htm EX-10.2 176596
8 ex10-3.htm EX-10.3 57145
  Complete submission text file 0001493152-23-039170.txt   1296614

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE vvos-20231102.xsd EX-101.SCH 3006
10 XBRL LABEL FILE vvos-20231102_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE vvos-20231102_pre.xml EX-101.PRE 22353
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3424
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 231373515
SIC: 3841 Surgical & Medical Instruments & Apparatus